IMARC Group’s report titled “United States In Vitro Fertilization Market Report by Product (Reagent, Instrument, Accessories), Procedure Type (Fresh Donor, Frozen Donor, Fresh Non-donor, Frozen Non-donor), Cycle Type (Conventional IVF, IVF with ICSI, IVF with Donor Eggs), End User (Fertility Clinics, Hospitals, and Others), and Region 2024-2032” The United States in vitro fertilization market size is projected to exhibit a growth rate (CAGR) of 5.75% during 2024-2032.
The changing lifestyle of the population with delayed parenthood, as well as advancements in reproductive technologies, are the factors responsible for the growth of the United States in vitro fertilization market. Additionally, the growing incidence of infertility, which is influenced by factors such as lifestyle changes, environmental toxins, and underlying health conditions, is fueling the market. Besides this, increased awareness and social acceptance of IVF and other assisted reproductive technologies (ART) are encouraging more individuals and couples to seek these treatments, further bolstering the market. Moreover, the availability of financing options and insurance coverage for fertility treatments in some states also plays a crucial role in making IVF more accessible to a broader population.
Grab a sample PDF of this report: https://www.imarcgroup.com/united-states-in-vitro-fertilization-market/requestsample
United States In Vitro Fertilization Market Trends and Drivers:
Technological advancements in reproductive medicine are significantly enhancing the success rates and appeal of procedures, further augmenting the market. In addition to this, innovations such as preimplantation genetic testing (PGT) allow for the screening of embryos for genetic abnormalities before implantation, increasing the chances of a healthy pregnancy and reducing the risk of genetic disorders, which are acting as another growth-inducing factor. Furthermore, the market is positively impacted by the development of advanced laboratory techniques and cryopreservation methods, including egg and embryo freezing, which provides greater flexibility and options for patients. In line with this, the trend towards personalized medicine is evident in the IVF market, as treatments are increasingly tailored to the individual needs of patients based on their unique medical profiles, which is anticipated to drive the United States in vitro fertilization market over the forecasted period.
Report Segmentation:
The report has segmented the market into the following categories:
Product Insights:
- Reagent
- Cryopreservation Media
- Embryo Culture Media
- Ovum Processing Media
- Sperm Processing Media
- Instrument
- Imaging Systems
- Incubators
- Cryosystems
- IVF Cabinet
- Ovum Aspiration Pump
- Sperm Separation Systems
- Micromanipulator Systems
- Others
- Accessories
Procedure Type Insights:
- Fresh Donor
- Frozen Donor
- Fresh Non-donor
- Frozen Non-donor
Cycle Type Insights:
- Conventional IVF
- IVF with ICSI
- IVF with Donor Eggs
End User Insights:
- Fertility Clinics
- Hospitals
- Others
Regional Insights:
- Northeast
- Midwest
- South
- West
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163